ITADs long-term evaluation of the UK Government’s flagship Fleming Fund has informed strategic shifts relating to data use and gender equity to reduce disease, illness and death from drug resistance.
AMR is an important global public health challenge, but there is a lack of good data on response progress. This study addresses country governance of antimicrobial resistance (AMR) surveillance, considering changes in responses to the Tracking Antimicrobial Resistance Country Self-Assessment Survey (TrACSS) between 2019 and 2024. Its first objective is to describe progress under the global action agenda on AMR. Its second objective is to assess the effectiveness of a major development aid intervention to encourage action against AMR, the United Kingdom (UK)-funded Fleming Fund (FF). The study applies a pragmatic approach to analysis, involving descriptive exploration and difference-in-differences methodology.
The latest paper from the Fleming Fund Regional Grant team, GEAR up, argues that current action on AMR fails to adequately address the social and political determinants that create vulnerability and the (gendered) power relations sustaining inequity.
GRAM opens global AMR data repository to researchers
by FlemingfundThe Global Research on Antimicrobial Resistance (GRAM) Project is inviting researchers worldwide to access and utilise its extensive antimicrobial resistance (AMR) data repository, hosted by the Infectious Diseases Data Observatory (IDDO).
Two landmark projects aimed at strengthening the Caribbean’s capacity to fight antimicrobial resistance (AMR) were launched on 5 May, at an event in Barbados with regional and international health leaders in attendance.
12 Dec 2023 Webinar where experts on gender and antimicrobial resistance (AMR) discuss key issues such as:
- What difference does gender and sex make to who carries the greatest burden of AMR in a community?
- How does gender intersect with other social and cultural factors to intensify vulnerability to AMR?
- What are the implications of these insights for health researchers, donors and policymakers?
Using intersectionality to study gender and antimicrobial resistance in low- and middle-income countries
by JMC Gautron et alDifferent sexes and genders experience differentiated risks of acquiring infections, including drug-resistant infections, and of becoming ill. Different genders also have different health-seeking behaviours that shape their likelihood of having access to and appropriately using and administering antimicrobials. Consequently, they are distinctly affected by antimicrobial resistance (AMR). As such, it is crucial to incorporate perspectives on sex and gender in the study of both AMR and antimicrobial use in order to present a full picture of AMR’s drivers and impact.